Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Connect with investors, share insights, and grow together
Stay up to date on latest investing trends and other announcements
Explore our range of financial tools to streamline your investment planning
A structured, comprehensive way to understand global investing
Read about our journey and get to know the leadership team at Vested
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is a modified equal-dollar weighted index to objectively identify and select stocks from the Russell 1000® Index in the health care sector that may generate positive alpha relative to traditional passive-style indices through the use of the AlphaDEX® selection methodology. more
| Time Frame | FXH | S&P500 |
|---|---|---|
| 1-Week Return | -1.51% | 0.5% |
| 1-Month Return | 3.8% | 3.86% |
| 3-Month Return | 15.31% | 1.92% |
| 6-Month Return | 15.76% | 12.03% |
| 1-Year Return | 24.69% | 18.56% |
| 3-Year Return | 29.1% | 73.83% |
| 5-Year Return | 6.16% | 70.11% |
| 10-Year Return | 118.97% | 252.93% |
| Time Frame | FXH | S&P500 |
|---|---|---|
| 1-Week Return | -54.77% | 29.70% |
| 1-Month Return | 57.42% | 58.53% |
| 3-Month Return | 78.20% | 8.02% |
| 6-Month Return | 34.55% | 25.90% |
| 1-Year Return | 24.69% | 18.56% |
| 3-Year Return | 8.89% | 20.24% |
| 5-Year Return | 1.20% | 11.21% |
| 10-Year Return | 8.15% | 13.44% |
| Stock name | Ticker | Weight |
|---|---|---|
Regeneron Pharmaceuticals, Inc. | REGN | 2.77% |
Natera, Inc. | NTRA | 2.67% |
Solventum Corporation | SOLV | 2.52% |
Pfizer Inc. | PFE | 2.49% |
Universal Health Services, Inc. (Class B) | UHS | 2.48% |
Zimmer Biomet Holdings, Inc. | ZBH | 2.47% |
Guardant Health, Inc. | GH | 2.4% |
Boston Scientific Corporation | BSX | 2.34% |
Tenet Healthcare Corporation | THC | 2.29% |
Globus Medical, Inc. (Class A) | GMED | 2.24% |
Halozyme Therapeutics, Inc. | HALO | 2.18% |
Centene Corporation | CNC | 2.18% |
The Cigna Group | CI | 2.16% |
Corcept Therapeutics Inc. | CORT | 2.15% |
ResMed Inc. | RMD | 1.93% |
Encompass Health Corporation | EHC | 1.89% |
Medline Inc. (Class A) | MDLN | 1.88% |
Medtronic Plc | MDT | 1.84% |
Axsome Therapeutics, Inc. | AXSM | 1.8% |
Incyte Corporation | INCY | 1.8% |
QIAGEN N.V. | QGEN | 1.79% |
Arrowhead Pharmaceuticals, Inc. | ARWR | 1.74% |
DaVita Inc. | DVA | 1.72% |
Zoetis Inc. | ZTS | 1.67% |
Elevance Health Inc. | ELV | 1.65% |
Becton, Dickinson and Company | BDX | 1.6% |
Doximity, Inc. (Class A) | DOCS | 1.58% |
Eli Lilly and Company | LLY | 1.57% |
United Therapeutics Corporation | UTHR | 1.56% |
Labcorp Holdings Inc. | LH | 1.54% |
Revolution Medicines, Inc. | RVMD | 1.52% |
Gilead Sciences, Inc. | GILD | 1.51% |
Ascendis Pharma A/S | ASND | 1.49% |
Bristol-Myers Squibb Company | BMY | 1.49% |
Medpace Holdings, Inc. | MEDP | 1.48% |
Quest Diagnostics Incorporated | DGX | 1.48% |
Neurocrine Biosciences, Inc. | NBIX | 1.48% |
GE HealthCare Technologies Inc. | GEHC | 1.45% |
Steris Plc | STE | 1.42% |
Viatris Inc. | VTRS | 1.37% |
Biogen Inc. | BIIB | 1.32% |
Exelixis, Inc. | EXEL | 1.3% |
Veeva Systems Inc. (Class A) | VEEV | 1.27% |
IQVIA Holdings Inc. | IQV | 1.08% |
Ionis Pharmaceuticals, Inc. | IONS | 1.01% |
Thermo Fisher Scientific Inc. | TMO | 1% |
Abbott Laboratories | ABT | 0.98% |
Tempus AI, Inc. (Class A) | TEM | 0.97% |
Agilent Technologies, Inc. | A | 0.95% |
Chemed Corporation | CHE | 0.89% |
Vertex Pharmaceuticals Incorporated | VRTX | 0.88% |
Henry Schein, Inc. | HSIC | 0.86% |
HCA Healthcare, Inc. | HCA | 0.86% |
BridgeBio Pharma, Inc. | BBIO | 0.84% |
AbbVie Inc. | ABBV | 0.82% |
Organon & Co. | OGN | 0.81% |
Madrigal Pharmaceuticals, Inc. | MDGL | 0.81% |
Align Technology, Inc. | ALGN | 0.75% |
Bio-Rad Laboratories, Inc. (Class A) | BIO | 0.53% |
DexCom, Inc. | DXCM | 0.53% |
Illumina, Inc. | ILMN | 0.52% |
Amgen Inc. | AMGN | 0.48% |
Revvity, Inc. | RVTY | 0.47% |
Merck & Co., Inc. | MRK | 0.46% |
BioMarin Pharmaceutical Inc. | BMRN | 0.46% |
Danaher Corporation | DHR | 0.45% |
The Ensign Group, Inc. | ENSG | 0.43% |
Johnson & Johnson | JNJ | 0.42% |
Envista Holdings Corporation | NVST | 0.42% |
IDEXX Laboratories, Inc. | IDXX | 0.41% |
Stryker Corporation | SYK | 0.41% |
The Cooper Companies, Inc. | COO | 0.4% |
West Pharmaceutical Services, Inc. | WST | 0.39% |
US Dollar | US.Dollar | 0.22% |
| Sector | Weight |
|---|---|
|
Health care | 100.00% |
First Trust Health Care AlphaDEX® Fund (FXH) share price today is $132.77.
Yes, Indians can buy shares of First Trust Health Care AlphaDEX® Fund (FXH) on Vested. To buy FXH from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of First Trust Health Care AlphaDEX® Fund (FXH) on Vested. You can start investing in First Trust Health Care AlphaDEX® Fund (FXH) with a minimum investment of $1.
The 52-week high price of First Trust Health Care AlphaDEX® Fund (FXH) is $135.82. The 52-week low price of First Trust Health Care AlphaDEX® Fund (FXH) is $104.36.
The stock symbol (or ticker) of First Trust Health Care AlphaDEX® Fund is FXH.
Yes, you can setup SIP in First Trust Health Care AlphaDEX® Fund shares. Follow the below steps to create the SIP:
Here is the historical performance of FXH on the Vested app.
The expense ratio of First Trust Health Care AlphaDEX® Fund (FXH) is 0.62%.
Link copied